Which companies overlap with Sichuan Center for Disease Control and Prevention's portfolio?

Top competitors by shared drug class: Biomed Industries, Inc., Centers for Disease Control and Prevention, GlaxoSmithKline, Hospital Clinic of Barcelona, Institute of Medical Biology, Chinese Academy of Medical Sciences.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sichuan-center-for-disease-control-and-prevention.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Sichuan Center for Disease Control and Prevention — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sichuan Center for Disease Control and Prevention pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
measles-rubella vaccine	measles-rubella vaccine	marketed	Live attenuated viral vaccine		Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biomed Industries, Inc. · 1 shared drug class
Centers for Disease Control and Prevention · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hospital Clinic of Barcelona · 1 shared drug class
Institute of Medical Biology, Chinese Academy of Medical Sciences · 1 shared drug class
Institute of Tropical Medicine, Belgium · 1 shared drug class
International Vaccine Institute · 1 shared drug class
AstraZeneca · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sichuan Center for Disease Control and Prevention:

Cite this brief

Drug Landscape (2026). Sichuan Center for Disease Control and Prevention — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sichuan-center-for-disease-control-and-prevention. Accessed 2026-05-17.